12006550

Source:http://linkedlifedata.com/resource/pubmed/id/12006550

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0029463, umls-concept:C0035647, umls-concept:C0086418, umls-concept:C0206588, umls-concept:C0243192, umls-concept:C0281375, umls-concept:C0450442
pubmed:issue	5
pubmed:dateCreated	2002-5-13
pubmed:abstractText	This study was designed to investigate whether nuclear receptor agonists can be used as potential differentiation therapy agents for human osteosarcoma.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Chromans, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoplasmic and Nuclear, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Retinoid X Receptors, http://linkedlifedata.com/resource/pubmed/chemical/Thiazoles, http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Tretinoin, http://linkedlifedata.com/resource/pubmed/chemical/alitretinoin, http://linkedlifedata.com/resource/pubmed/chemical/ciglitazone, http://linkedlifedata.com/resource/pubmed/chemical/troglitazone
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1078-0432
pubmed:author	pubmed-author:BreyerBenjaminB, pubmed-author:ChengHongweiH, pubmed-author:FengTaoT, pubmed-author:HaydonRex CRC, pubmed-author:HeTong-ChuanTC, pubmed-author:IshikawaAkiraA, pubmed-author:MontagAnthonyA, pubmed-author:PeabodyTerranceT, pubmed-author:SimonMichael AMA, pubmed-author:WeiJiangJ, pubmed-author:ZhouLanL
pubmed:issnType	Print
pubmed:volume	8
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1288-94
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12006550-Antineoplastic Agents, pubmed-meshheading:12006550-Apoptosis, pubmed-meshheading:12006550-Cell Differentiation, pubmed-meshheading:12006550-Cell Division, pubmed-meshheading:12006550-Chromans, pubmed-meshheading:12006550-Dose-Response Relationship, Drug, pubmed-meshheading:12006550-Drug Synergism, pubmed-meshheading:12006550-Gene Expression Regulation, Neoplastic, pubmed-meshheading:12006550-HT29 Cells, pubmed-meshheading:12006550-Humans, pubmed-meshheading:12006550-Osteosarcoma, pubmed-meshheading:12006550-RNA, Neoplasm, pubmed-meshheading:12006550-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:12006550-Receptors, Retinoic Acid, pubmed-meshheading:12006550-Retinoid X Receptors, pubmed-meshheading:12006550-Thiazoles, pubmed-meshheading:12006550-Thiazolidinediones, pubmed-meshheading:12006550-Time Factors, pubmed-meshheading:12006550-Transcription Factors, pubmed-meshheading:12006550-Tretinoin, pubmed-meshheading:12006550-Tumor Cells, Cultured
pubmed:year	2002
pubmed:articleTitle	Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
pubmed:affiliation	Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Illinois 60637, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't